Radiobiological characterization of proton beam at the national cancer center in Korea

Journal of Radiation Research

Volumn 49, Issue 5, 2008, Pages 509-515

  Baek, Hye Jung ^a   Kim, Tae Hyun ^a   Shin, Dongho ^a   Kwak, Jung Won ^a   Choo, Dong Wan ^a   Lee, Se Byung ^a   Furusawa, Yoshiya ^b   Ando, Koichi ^b   Kim, Sang Soo ^a   Cho, Kwan Ho ^a  

^a National Cancer Center   (South Korea)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Colonogenic assay; MTT assay; Proton beam therapy; RBE

Indexed keywords

ASSAYS; DISEASES; PROTON BEAM THERAPY;

CHARACTERISTIC DEPTHS; COLONOGENIC ASSAY; DEPTH DEPENDENTS; GLAND CELLS; MTT ASSAYS; NATIONAL CANCER CENTERS; PROTON THERAPY; RELATIVE BIOLOGICAL EFFECTIVENESS; SALIVARY GLANDS; SPREAD OUT BRAGG PEAKS;

PROTON BEAMS;

EID: 52249102648     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.08017     Document Type: Article

References (18)

1. Gueulette, J., Blattmann, H., Pedroni, E., Coray, A.. De Coster, B. M., Mahy, P., Wambersie, A. and Goitein, G. (2005) Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion. Int. J. Radiat. Oncol. Biol. Phys. 62: 838-845.
2. Paganetti, H., Niemierko, A., Ancukiewicz, M., Gerweck, L. E., Goitein, M., Loeffler, J. S. and Suit, H. D. (2002) Relative biological effectiveness (RBE) values for proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 53: 407-421.
3. Mason, K. A., Gillin, M. T., Mohan, R. and Cox, J. D. (2007) Preclinical biologic assessment of proton beam relative biologic effectiveness at Proton Therapy Center Houston. Int. J. Radiat. Oncol. Biol. Phys. 68: 968-970.
4. Furusawa, Y., Fukutsu, K., Aoki, M., Itsukaichi, H., Eguchi-Kasai, K., Ohara, H., Yatagai, F., Kanai, T. and Ando, K. (2000) Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Neion beams. Radiat. Res. 154: 485-496.
5. IAEA (2000) IAEA TRS-398, Absorbed dose determination in external beamradiotherapy:Anintemational code of practice for dosimetry based on standards of absorbed dose to water. In Vienna: International Atomic Energy Agency.
6. Ando. K.. Furusawa, Y., Suzuki, M., Nojima, K., Majima, H., Koike, S., Aoki, M., Shimizu, W., Futami, Y., Ogino, T., Murayama, S. and Ikeda, H. (2001) Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East. J. Radiat. Res. 42: 79-89.
7. Baek, H. J., Kim, S. S., da Silva, F. M., Volpe, E. A., Evans, S., Mishra, B., Mishra, L. and Marshall, M. B. (2006) Inactivation of TGF-beta signaling in lung cancer results in increased CDK4 activity that can be rescued by ELF. Bio-chem. Biophys. Res. Commun. 346: 1150-1157.
8. Kim, S. S., Cao, L., Lim, S. C, Li, C, Wang, R. H., Xu, X., Bachelier, R. and Deng, C. X. (2006) Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform. Mol. Cell. Biol. 26: 6983-6992.
9. Yang, H., Asaad, N. and Held, K. D. (2005) Medium-mediated intercellular communication is involved in bystander responses of X-ray-irradiated normal human fibroblasts. Oncogene 24: 2096-2103.
10. Fernandez-Capetillo, O., Lee, A., Nussenzweig, M. and Nussenzweig, A. (2004) H2AX: the histone guardian of the genome. DNA Repair (Amst) 3: 959-967.
11. Kagawa, K., Murakami, M., Hishikawa, Y., Abe, M., Akagi, T., Yanou, T., Kagiya, G., Furusawa, Y., Ando, K., Nojima, K., Aoki, M. and Kanai, T. (2002) Preclinical biological assessment of proton and carbon ion beams at Hyogo Ion Beam Medical Center. Int. J. Radiat. Oncol. Biol. Phys. 54: 928-938.
12. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotox-icity assays. J. Immunol. Methods 65: 55-63.
13. Wilson, A. P. (2000) Cytotoxicity and Viability Assays in Animal Cell Culture: A Practical Approach, 3rd ed, Oxford University Press, Oxford.
14. Gerweck, L. E. and Kozin, S. V. (1999) Relative biological effectiveness of proton beams in clinical therapy. Radiother. Oncol. 50: 135-142.
15. Raju, M. R. (1995) Proton radiobiology, radiosurgery and radiotherapy. Int. J. Radiat. Biol. 67: 237-259.
16. IAEA (2008) IAEA TRS-461, Relative biological effectiveness in ion beam therapy. In Vienna: International Atomic Energy Agency.
17. Shioyama, Y., Tokuuye, K., Okumura, T., Kagei, K., Sugahara, S., Ohara, K., Akine, Y., Ishikawa, S., Satoh, H. and Sekizawa, K. (2003) Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 56: 7-13
18. Igaki, H., Tokuuye, K., Okumura, T., Sugahara, S., Kagei, K., Hata, M., Ohara, K., Hashimoto, T., Tsuboi, K., Takano, S., Matsumura, A. and Akine, Y. (2004) Clinical results of proton beam therapy for skull base chordoma. Int. J. Radiat. Oncol. Biol. Phys. 60: 1120-1126.